Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.

Autor: Smolen JS, van der Heijde DMF, St. Clair EW, Emery P, Bathon JM, Keystone E, Maini RN, Kalden JR, Schiff M, Baker D, Han C, Han J, Bala M

Publikováno v: Arthritis & Rheumatism; Mar2006, Vol. 54 Issue 3, p702-710, 9p

What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the outcome measures in rheumatology clinical trials filter.

Autor: Wanders AJB, Landewé RBM, Spoorenberg A, Dougados M, van der Linden S, Mielants H, van der Tempel H, van der Heijde DMF

Publikováno v: Arthritis & Rheumatism; Aug2004, Vol. 50 Issue 8, p2622-2632, 11p

Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis.

Autor: Wanders AJB, Gorman JD, Davis JC, Landewe RBM, van der Heijde DMF

Publikováno v: Arthritis & Rheumatism: Arthritis Care & Research; 2004 Feb 15, Vol. 51 Issue 1, p1-8, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Autor: Boers M (AUTHOR), Verhoeven AC (AUTHOR), Markusse HM (AUTHOR), van de Laar MAF (AUTHOR), Westhovens R (AUTHOR), van Denderen JC (AUTHOR), van Zeben D (AUTHOR), Dijkmans BAC (AUTHOR), Peeters AJ (AUTHOR), Jacobs P (AUTHOR), van den Brink HR (AUTHOR), Schouten HJA (AUTHOR), van der Heijde DMF (AUTHOR), Boonen A (AUTHOR), van der Linden S (AUTHOR)

Publikováno v: Lancet. 8/2/1997, Vol. 350 Issue 9074, p309-318. 10p.